Helmut R Maecke

Design and in vitro characterization of highly sst2-selective somatostatin antagonists suitable for radiotargeting.

Jean E Rivier, J. Rivier, J. Reubi, 2008, Journal of medicinal chemistry.

New Pansomatostatin Ligands and Their Chelated Versions: Affinity Profile, Agonist Activity, Internalization, and Tumor Targeting

S. Schulz, J. Reubi, Hanwen Zhang, 2008, Clinical Cancer Research.

Peptide-Based Probes for Cancer Imaging

J. Reubi, H. Maecke, Jean Claude Reubi, 2008, Journal of Nuclear Medicine.

Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs.

Giovanni Paganelli, Lisa Bodei, Stanislas Pauwels, 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Preclinical evaluation of new and highly potent analogues of octreotide for predictive imaging and targeted radiotherapy.

Martin A Walter, M. Walter, J. Reubi, 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

PET of Somatostatin Receptor–Positive Tumors Using 64Cu- and 68Ga-Somatostatin Antagonists: The Chelate Makes the Difference

Wolfgang A Weber, W. Weber, J. Reubi, 2011, The Journal of Nuclear Medicine.